Description
Tirzepatide Overview
Tirzepatide is a dual GIP and GLP-1 receptor agonist that has become one of the most extensively studied incretin-based compounds for blood-glucose control and weight management.
Note: Tirzepatide is sometimes incorrectly marketed as “GLP-1.2.” Its established pharmacology is GIP/GLP-1 receptor agonism.
Product Information
Tirzepatide activates both GIP and GLP-1 receptors. These pathways influence glucose-dependent insulin secretion, appetite signaling, gastric emptying, and energy balance.
Large clinical trials have demonstrated substantial body-weight reduction and improvements in glycemic measures.
How Does Tirzepatide Work?
Tirzepatide activates GIP and GLP-1 receptors, influencing glucose regulation, appetite, and energy balance.
Tirzepatide Benefits & Effects
Promotes Weight Reduction
Clinical trials have demonstrated substantial reductions in body weight with Tirzepatide compared with placebo.
Improves Blood-Glucose Control
Tirzepatide improves glucose-dependent insulin secretion and has demonstrated significant reductions in HbA1c.
Reduces Appetite
GIP and GLP-1 signaling influences satiety and food intake, contributing to reduced appetite.
Supports Metabolic Research
Tirzepatide is extensively studied in obesity, type 2 diabetes, and broader metabolic research.
Tirzepatide Side Effects
Common adverse effects include nausea, diarrhea, vomiting, constipation, abdominal discomfort, decreased appetite, and indigestion.
Tirzepatide Dosage
For FDA-approved tirzepatide products, treatment begins at 2.5 mg once weekly, followed by gradual dose increases. The approved maximum dosage is 15 mg once weekly.
These figures describe approved-product dosing and should not be automatically applied to unapproved or compounded products.
Where to Buy Tirzepatide?
Tirzepatide products are not sold by Purerawz. Purerawz provides informational content and may include affiliate links to third-party websites where products are listed.
Disclaimer: The information on Purerawz is educational only and is not medical advice. Approved tirzepatide products should be used according to their official prescribing information.
Research Reference:
Reviews
There are no reviews yet.